Cargando…
Paradoxic effects of metformin on endothelial cells and angiogenesis
The biguanide metformin is used in type 2 diabetes management and has gained significant attention as a potential cancer preventive agent. Angioprevention represents a mechanism of chemoprevention, yet conflicting data concerning the antiangiogenic action of metformin have emerged. Here, we clarify...
Autores principales: | Dallaglio, Katiuscia, Bruno, Antonino, Cantelmo, Anna R., Esposito, Alessia I., Ruggiero, Luca, Orecchioni, Stefania, Calleri, Angelica, Bertolini, Francesco, Pfeffer, Ulrich, Noonan, Douglas M., Albini, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004203/ https://www.ncbi.nlm.nih.gov/pubmed/24419232 http://dx.doi.org/10.1093/carcin/bgu001 |
Ejemplares similares
-
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
por: Talarico, Giovanna, et al.
Publicado: (2016) -
Orchestration of Angiogenesis by Immune Cells
por: Bruno, Antonino, et al.
Publicado: (2014) -
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
por: Albini, Adriana, et al.
Publicado: (2015) -
Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation
por: Gallo, Cristina, et al.
Publicado: (2016) -
Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
por: Orecchioni, Stefania, et al.
Publicado: (2018)